Hong Kong-listed company IVD Medical invests $19 million in Ethereum
According to Jinse Finance, Hong Kong-listed company IVD Medical Holdings has announced the purchase of Ethereum worth 19 million US dollars (approximately 149 million Hong Kong dollars) to support its medical asset tokenization strategy. The company is developing a platform called ivd.xyz based on Ethereum smart contracts, aiming to tokenize pharmaceutical intellectual property and medical assets.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
